109 related articles for article (PubMed ID: 9310083)
1. Plasma fibrinogen levels in healthy postmenopausal women: physical activity and hormone replacement status.
DeSouza CA; Stevenson ET; Davy KP; Jones PP; Seals DR
J Gerontol A Biol Sci Med Sci; 1997 Sep; 52(5):M294-8. PubMed ID: 9310083
[TBL] [Abstract][Full Text] [Related]
2. Plasma C-reactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy.
Stauffer BL; Hoetzer GL; Smith DT; DeSouza CA
J Appl Physiol (1985); 2004 Jan; 96(1):143-8. PubMed ID: 12949021
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure risks factors in healthy postmenopausal women: physical activity and hormone replacement.
Stevenson ET; Davy KP; Jones PP; Desouza CA; Seals DR
J Appl Physiol (1985); 1997 Feb; 82(2):652-60. PubMed ID: 9049749
[TBL] [Abstract][Full Text] [Related]
4. Distribution and correlates of plasma fibrinogen in middle-aged women. Initial findings of the Postmenopausal Estrogen/Progestin Interventions (PEPI) study.
Stefanick ML; Legault C; Tracy RP; Howard G; Kessler CM; Lucas DL; Bush TL
Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2085-93. PubMed ID: 7489228
[TBL] [Abstract][Full Text] [Related]
5. Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapy.
Lee AJ; Lowe GD; Smith WC; Tunstall-Pedoe H
Br J Haematol; 1993 Apr; 83(4):616-21. PubMed ID: 8518178
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
[TBL] [Abstract][Full Text] [Related]
7. Physical activity, hormone replacement therapy and plasma lipoprotein-lipid levels in postmenopausal women.
Hagberg JM; McCole SD; Ferrell RE; Zmuda JM; Rodgers KS; Wilund KR; Moore GE
Int J Sports Med; 2003 Jan; 24(1):22-9. PubMed ID: 12582948
[TBL] [Abstract][Full Text] [Related]
8. Effects of hormone replacement therapies on fibrinogen and plasma viscosity in postmenopausal women.
Fröhlich M; Schunkert H; Hense HW; Tropitzsch A; Hendricks P; Döring A; Riegger GA; Koenig W
Br J Haematol; 1998 Mar; 100(3):577-81. PubMed ID: 9504644
[TBL] [Abstract][Full Text] [Related]
9. Insulin sensitivity in postmenopausal women: independent and combined associations with hormone replacement, cardiovascular fitness, and body composition.
Brown MD; Korytkowski MT; Zmuda JM; McCole SD; Moore GE; Hagberg JM
Diabetes Care; 2000 Dec; 23(12):1731-6. PubMed ID: 11128342
[TBL] [Abstract][Full Text] [Related]
10. Regular exercise, hormone replacement therapy and the age-related decline in carotid arterial compliance in healthy women.
Moreau KL; Donato AJ; Seals DR; DeSouza CA; Tanaka H
Cardiovasc Res; 2003 Mar; 57(3):861-8. PubMed ID: 12618248
[TBL] [Abstract][Full Text] [Related]
11. Body composition modulates the effects of hormone replacement therapy on growth hormone and insulin-like growth factor-I levels in postmenopausal women.
Figueroa A; Going SB; Milliken LA; Blew R; Sharp S; Lohman TG
Gynecol Obstet Invest; 2002; 54(4):201-6. PubMed ID: 12592062
[TBL] [Abstract][Full Text] [Related]
12. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
Gower BA; Nagy TR; Goran MI; Smith A; Kent E
J Clin Endocrinol Metab; 2000 May; 85(5):1770-5. PubMed ID: 10843150
[TBL] [Abstract][Full Text] [Related]
13. Influence of body fatness on the coronary risk profile of physically active postmenopausal women.
Tanaka H; Clevenger CM; Jones PP; Seals DR; DeSouza CA
Metabolism; 1998 Sep; 47(9):1112-20. PubMed ID: 9751241
[TBL] [Abstract][Full Text] [Related]
14. Inverse relationship between physical activity and plasma fibrinogen in postmenopausal women.
Rankinen T; Rauramaa R; Väisänen S; Penttilä I; Saarikoski S; Tuomilehto J; Nissinen A
Atherosclerosis; 1993 Sep; 102(2):181-6. PubMed ID: 8251004
[TBL] [Abstract][Full Text] [Related]
15. The relationship between fat distribution and coronary risk factors in sedentary postmenopausal women on and off hormone replacement therapy.
Perry AC; Allison M; Applegate EB; Jackson ML; Miller PC
Obes Res; 1998 Jan; 6(1):40-6. PubMed ID: 9526969
[TBL] [Abstract][Full Text] [Related]
16. Determinants of body composition in postmenopausal women.
Hagberg JM; Zmuda JM; McCole SD; Rodgers KS; Wilund KR; Moore GE
J Gerontol A Biol Sci Med Sci; 2000 Oct; 55(10):M607-12. PubMed ID: 11034234
[TBL] [Abstract][Full Text] [Related]
17. [Effect of hormone replacement therapy on coagulation function in postmenopausal women].
Ye Y; Gao P; Guo X
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):285-7. PubMed ID: 11775909
[TBL] [Abstract][Full Text] [Related]
18. Hemostatic factors according to menopausal status and use of hormone replacement therapy.
Meilahn EN; Kuller LH; Matthews KA; Kiss JE
Ann Epidemiol; 1992 Jul; 2(4):445-55. PubMed ID: 1342295
[TBL] [Abstract][Full Text] [Related]
19. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
Lai A; Zhang J; Ding L
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
[TBL] [Abstract][Full Text] [Related]
20. Hemostatic, metabolic, and androgenic risk factors for coronary heart disease in physically active and less active postmenopausal women.
Stevenson ET; Davy KP; Seals DR
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):669-77. PubMed ID: 7749880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
